BDWM
MRNA icon

Brewin Dolphin Wealth Management’s Moderna MRNA Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$38K Hold
268
– – ﹤0.01% 206
2022
Q1 		$46K Buy
268
+184
+219% +$31K 0.01% 198
2021
Q4 		$21K Sell
84
-170
-67% -$49.7K ﹤0.01% 258
2021
Q3 		$97.8K Sell
254
-55
-18% -$20.3K 0.01% 158
2021
Q2 		$72.6K Buy
309
+225
+268% +$40.2K 0.01% 169
2021
Q1 		$11K Sell
84
-140
-63% -$20.3K ﹤0.01% 286
2020
Q4 		$23.4K Buy
224
+140
+167% +$14.2K ﹤0.01% 217
2020
Q3 		$5.94K Buy
+84
New +$5.86K ﹤0.01% 250

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brewin Dolphin Wealth Management's MRNA Position: Q2 2022 in Review

Brewin Dolphin Wealth Management held its Moderna (MRNA) position steady in Q2 2022 at 268 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #206.

Brewin Dolphin Wealth Management first reported a position in MRNA in Q3 2020 and has held it in 8 quarters since. The position peaked at $97.8K in Q3 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Brewin Dolphin Wealth Management held 268 shares of Moderna worth $38K as of Q2 2022.
  • Brewin Dolphin Wealth Management left its Moderna share count unchanged in Q2 2022.
  • Moderna made up ﹤0.01% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #206 holding.
  • Brewin Dolphin Wealth Management first reported a position in Moderna in Q3 2020 and has held it in 8 quarters since.
  • Brewin Dolphin Wealth Management's Moderna position peaked at $97.8K in Q3 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.